Clínic Barcelona

A European project led by IDIBAPS will test a diagnostic genomic test for breast cancer to improve patients' quality of life

The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of life in patients with early-stage HER2+ breast cancer while also maintaining drug efficacy.

Team of DEFINITIVE Project

Team of DEFINITIVE Project at the Kickoff meeting

Related contents
Keep reading about: